Non-Small Cell Lung Cancer

  • Zykadia 2017 report

    Zykadia 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Abraxane 2016 report

    Abraxane 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Alecensa 2016 report

    Alecensa 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Alimta 2016 report

    Alimta 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Avastin 2016 report

    Avastin 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Cyramza 2016 report

    Cyramza 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Gilotrif 2016 report

    Gilotrif 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Iressa 2016 report

    Iressa 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Keytruda 2016 report

    Keytruda 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Opdivo 2016 report

    Opdivo 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Portrazza 2016 report

    Portrazza 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Tagrisso 2016 report

    Tagrisso 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...